Marrow Access Technologies Launches SmartShot Marrow Access Device

Marrow Access Technologies announced full U.S. market release of the SmartShot Marrow Access Device.

During limited market release, SmartShot was used to treat hundreds of patients suffering from orthopedic injuries, including applications in the knee, shoulder, ankle, hip, and elbow. SmartShot uses a patented mechanism to create 1mm channels into bone to stimulate the patient’s own healing reaction. The penetration of the outer layers of bone allows blood and stem cells to activate cartilage, ligament, and tendon healing. In a recently published independently funded and peer-reviewed study, bioengineering scientists at the University of Pennsylvania concluded that SmartShot best preserved the underlying subchondral bone compared to traditional marrow access approaches.

SmartShot is commercially available in the United States with rapidly expanding distribution.

Source: Marrow Access Technologies